YOLFTbeta
Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc.

WHWK · NASDAQ · Healthcare / Biotechnology

3.06USD-0.01 (-0.33%)

Price History

Full chart

Market Stats

Previous Close3.07
Open3.07
Day Range2.91 – 3.11
52-Week Range1.86 – 5.50
Volume212.18K
Market Cap212.64M
P/E (TTM)0.00
Forward P/E2.66
EPS-1.20
Dividend Yield0.00%
Beta0.81
50-Day Avg4.29
200-Day Avg3.75

About

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. David J. Lennon Ph.D.
  • Employees32
  • Headquarters2 Headquarters Plaza, Morristown, NJ, United States, 07960, USA
  • Websitehttps://ir.whitehawktx.com

Leadership

  • Dr. David J. Lennon Ph.D.President, CEO & Director · b. 1971
  • Dr. Neil P. Desai Ph.D.Founder & Director · b. 1965
  • Mr. Scott M. Giacobello CPACFO, Treasurer, Investor Relations & Corporate Communications · b. 1970
  • Mr. Bryan BallChief Technical Operations Officer · b. 1970
  • Dr. David Dornan Ph.D.Chief Scientific Officer · b. 1978
  • Mr. Stephen M. Rodin J.D.Senior VP of Legal & General Counsel · b. 1976
  • Dr. Margaret Han Dugan M.D.Chief Medical Officer · b. 1957

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue749.00K14.58M1.12M15.22M24.35M25.98M7.14M
Growth (%)-+1846.60%-92.32%+1258.57%+60.06%+6.69%-72.50%
Cost of Revenue11.06M15.01M19.67M34.00M51.74M54.05M760.00K
Gross Profit-10.32M-428.00K-18.55M-18.78M-27.38M-28.07M6.38M
Gross Margin-1377.23%-2.94%-1656.25%-123.43%-112.44%-108.04%89.36%
Operating Expense1.85M2.12M92.67M43.90M44.55M39.39M120.78M
Operating Income-12.17M-2.55M-111.22M-62.68M-71.93M-67.46M-114.40M
Operating Margin-1624.81%-17.48%-9930.09%-411.94%-295.36%-259.62%-1601.12%
EBITDA-12.16M-2.54M-36.96M-58.80M-65.36M-64.63M-20.52M
EBITDA Margin-1624.01%-17.42%-3299.64%-386.42%-268.40%-248.73%-287.15%
Net Income-12.26M-3.48M-110.09M-60.51M-65.77M-63.69M-20.60M
Net Income Margin-1636.19%-23.85%-9829.46%-397.69%-270.04%-245.13%-288.26%
R&D11.06M15.01M19.67M32.66M48.93M51.03M90.96M
R&D as % of Total Revenue1477.23%102.94%1756.25%214.66%200.91%196.40%1273.10%
Interest Expense83.94K815.00K665.00K230.00K231.00K154.00K0
Interest Expense % of Total Revenue11.21%5.59%59.38%1.51%0.95%0.59%0.00%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.66M18.82M157.91M184.24M132.42M70.32M150.83M
Total Liabilities25.75M31.26M21.50M25.86M27.23M17.84M14.52M
Total Equity-9.09M-12.43M136.41M158.38M105.19M52.48M136.31M
Cash15.96M4.46M148.99M39.02M62.89M28.67M37.57M
Total Debt8.49M10.26M605.00K1.66M1.27M833.00K-
Net Debt-7.48M5.80M-148.38M-37.36M-61.62M-27.84M-37.57M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.58M-12.70M-22.42M-49.64M-59.66M-59.55M-97.43M
Investing Cash Flow-35.71K-25.15M-132.89M83.21M25.20M11.89M
Financing Cash Flow8.07M1.19M141.80M72.62M326.00K130.00K94.38M
Capital Expenditure35.71K046.00K444.00K3.97M1.65M552.00K
Free Cash Flow-7.62M-12.70M-22.47M-50.08M-63.63M-61.20M-97.98M
Dividends Paid-04.41M0---
FCF to OCF100.47%100.00%100.21%100.89%106.66%102.78%100.57%
Dividend Paid to FCF-0.00%-19.64%0.00%---

Earnings

Report DateNov 29, 2017Mar 13, 2018May 15, 2018Aug 14, 2018Nov 7, 2018Mar 5, 2019May 9, 2019Aug 8, 2019Nov 7, 2019Mar 16, 2020May 7, 2020Aug 12, 2020Nov 10, 2020Mar 11, 2021May 17, 2021Aug 11, 2021Nov 10, 2021Mar 17, 2022May 12, 2022Aug 10, 2022Nov 9, 2022Mar 29, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Mar 13, 2024May 8, 2024Aug 7, 2024Nov 6, 2024Mar 18, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Mar 12, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-----------0.27-0.14-0.14-0.09-6.00-0.73-0.77-0.68-0.73-0.75-0.72-0.57-0.60-0.73-0.65-0.62-0.64-0.47-0.21-0.230.49-0.22-0.69-0.33-0.30-0.27
EPS Actual-2.59-3.47-4.12-3.294.22-3.15-3.14-2.10-1.72-1.64-1.450.23-0.12-0.10-0.09-1.35-1.42-0.77-0.66-0.69-0.68-0.48-0.57-0.67-0.60-0.60-0.68-0.54-0.37-0.67-0.36-0.76-0.25-0.34-0.32-0.20-
Surprise------------14.81%14.29%28.57%0.00%77.50%-94.52%0.00%2.94%5.48%9.33%33.33%0.00%-11.67%17.81%7.69%-9.68%15.63%21.28%-219.05%-56.52%-255.10%-13.64%50.74%3.03%33.33%-
Timing----------------Pre-market-Pre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hours-After-hoursPre-marketPre-market-After-hoursPre-marketAfter-hours-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap212.64M
Enterprise Value73.22M
Trailing P/E0.00
Forward P/E2.66
Price / Sales30.04
Price / Book1.20
EPS-1.20
Book Value2.46
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-86.06M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-44.98%
Return on Assets-28.70%
Shares Outstanding57.01M
Shares Float28.74M
Beta0.81
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 3 analystsTarget 7.50
  • Hold
    3

Ownership Breakdown

Institutions
81.00%
Insiders
12.62%
Retail / Other
6.38%

Top Institutional Holders

  • Longwood Capital Partners LLC
    4.69M8.22%
  • Qvt Financial LP
    4.62M8.10%
  • Orbimed Advisors LLC
    4.17M7.31%
  • Suvretta Capital Management, LLC
    3.70M6.49%
  • venBio Select Advisor LLC
    2.85M5.00%
  • KVP Capital Advisors, LP
    2.17M3.80%
  • Siren, L.L.C.
    2.08M3.65%
  • Yu Fan
    2.07M3.63%
  • StemPoint Capital LP
    1.88M3.30%
  • Vanguard Capital Management, LLC
    1.32M2.31%
  • Ally Bridge Group (NY) LLC
    817.94K1.43%
  • Balyasny Asset Management LLC
    550.44K0.97%
  • Geode Capital Management, LLC
    457.54K0.80%
  • Renaissance Technologies Corp
    428.62K0.75%
  • Millennium Management LLC
    380.41K0.67%
  • BlackRock Inc
    351.38K0.62%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    887.97K1.56%
  • iShares Russell 2000 ETF
    723.10K1.27%
  • Fidelity Small Cap Index
    352.61K0.62%
  • iShares Russell 2000 Value ETF
    310.11K0.54%

Stock Splits

  • Aug 27, 20211:15